Key result
Circulating extracellular miRNAs play a key role in the pathophysiology of obesity and obesity-associated metabolic syndrome, with potential applications as biomarkers and therapeutic targets.
Why the study?
The study was conducted to review the role of circulating miRNAs in the pathophysiology of obesity and explore their potential use as biomarkers and in therapy of obesity-associated metabolic syndrome.
Extracellular miRNAs, particularly those derived from adipose tissue, play a key role in intercellular communication in obesity and hold potential as biomarkers and therapeutic targets for obesity-associated metabolic syndrome.
Answers are grounded in this paper and cite their sources.
May inform future biomarker studies in obese patients; hypothesis-generating for miRNA-targeted therapies in metabolic syndrome.
Extracellular miRNAs are found in a variety of body fluids and mediate intercellular and interorgan communication, thus regulating gene expression and cellular metabolism. These miRNAs are secreted either in small vesicles/exosomes (sEV) or bound to proteins such as Argonaute and high-density lipoprotein. Both exosomal and protein-bound circulating miRNAs are altered in obesity. Although all tissues can contribute to changes in circulating miRNAs, adipose tissue itself is an important source of these miRNAs, especially those in sEVs. These are derived from both adipocytes and macrophages and participate in crosstalk between these cells, as well as peripheral tissues, including liver, skeletal muscle and pancreas, whose function may be impaired in obesity. Changes in levels of circulating miRNAs have also been linked to the beneficial effects induced by weight loss interventions, including diet, exercise and bariatric surgery, further indicating a role for these miRNAs as mediators of disease pathogenesis. Here, we review the role of circulating miRNAs in the pathophysiology of obesity and explore their potential use as biomarkers and in therapy of obesity-associated metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Brandão et al. (2021) conducted a review in Obesity. Extracellular miRNAs was evaluated. Circulating extracellular miRNAs play a key role in the pathophysiology of obesity and obesity-associated metabolic syndrome, with potential applications as biomarkers and therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: